Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1536

1.

Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands.

Denters MJ, Deutekom M, Fockens P, Bossuyt PM, Dekker E.

BMC Gastroenterol. 2009 Apr 24;9:28. doi: 10.1186/1471-230X-9-28.

2.

Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round.

Stegeman I, de Wijkerslooth TR, Mallant-Hent RC, de Groot K, Stroobants AK, Fockens P, Mundt M, Bossuyt PM, Dekker E.

BMC Gastroenterol. 2012 Jun 19;12:73. doi: 10.1186/1471-230X-12-73.

3.

Study protocol: population screening for colorectal cancer by colonoscopy or CT colonography: a randomized controlled trial.

de Wijkerslooth TR, de Haan MC, Stoop EM, Deutekom M, Fockens P, Bossuyt PM, Thomeer M, van Ballegooijen M, Essink-Bot ML, van Leerdam ME, Kuipers EJ, Dekker E, Stoker J.

BMC Gastroenterol. 2010 May 19;10:47. doi: 10.1186/1471-230X-10-47.

4.
5.

Screening for colorectal cancer with FOBT, virtual colonoscopy and optical colonoscopy: study protocol for a randomized controlled trial in the Florence district (SAVE study).

Sali L, Grazzini G, Carozzi F, Castiglione G, Falchini M, Mallardi B, Mantellini P, Ventura L, Regge D, Zappa M, Mascalchi M, Milani S.

Trials. 2013 Mar 15;14:74. doi: 10.1186/1745-6215-14-74.

6.

Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.

Denters MJ, Deutekom M, Bossuyt PM, Stroobants AK, Fockens P, Dekker E.

Gastroenterology. 2012 Mar;142(3):497-504. doi: 10.1053/j.gastro.2011.11.024. Epub 2011 Nov 19.

PMID:
22108194
7.

Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.

Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, Cardelli A, Castiglione G, Crosta C, DiPlacido R, Ferrari A, Ferraris R, Ferrero F, Fracchia M, Gasperoni S, Malfitana G, Recchia S, Risio M, Rizzetto M, Saracco G, Spandre M, Turco D, Turco P, Zappa M; SCORE2 Working Group-Italy.

J Natl Cancer Inst. 2005 Mar 2;97(5):347-57.

8.

Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.

van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E.

Gastroenterology. 2008 Jul;135(1):82-90. doi: 10.1053/j.gastro.2008.03.040. Epub 2008 Mar 25.

PMID:
18482589
9.

[Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].

Quintero E.

Gastroenterol Hepatol. 2009 Oct;32(8):565-76. doi: 10.1016/j.gastrohep.2009.01.179. Epub 2009 Jul 3. Review. Spanish.

PMID:
19577340
10.

Variations between endoscopists in rates of detection of colorectal neoplasia and their impact on a regional screening program based on colonoscopy after fecal occult blood testing.

Bretagne JF, Hamonic S, Piette C, Manfredi S, Leray E, Durand G, Riou F.

Gastrointest Endosc. 2010 Feb;71(2):335-41. doi: 10.1016/j.gie.2009.08.032. Epub 2009 Nov 17.

PMID:
19922930
11.

Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation.

Daniels K, McKee M.

J R Army Med Corps. 1995 Oct;141(3):142-50. Erratum in: J R Army Med Corps 1996 Feb;142(1):49.

PMID:
8568748
12.

Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test.

Heresbach D, Manfredi S, D'halluin PN, Bretagne JF, Branger B.

Eur J Gastroenterol Hepatol. 2006 Apr;18(4):427-33. Review.

PMID:
16538116
13.

Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.

Malila N, Oivanen T, Hakama M.

Z Gastroenterol. 2008 Apr;46 Suppl 1:S25-8. doi: 10.1055/s-2007-963490.

PMID:
18368636
14.

A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice.

Multicentre Australian Colorectal-neoplasia Screening (MACS) Group.

Med J Aust. 2006 Jun 5;184(11):546-50.

PMID:
16768659
15.
16.

French colorectal cancer screening pilot programme: results of the first round.

Goulard H, Boussac-Zarebska M, Ancelle-Park R, Bloch J.

J Med Screen. 2008;15(3):143-8. doi: 10.1258/jms.2008.008004. Erratum in: J Med Screen. 2008;15(4):214.

PMID:
18927097
17.

Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community.

Hughes K, Leggett B, Del Mar C, Croese J, Fairley S, Masson J, Aitken J, Clavarino A, Janda M, Stanton WR, Tong S, Newman B.

Aust N Z J Public Health. 2005 Aug;29(4):358-64.

PMID:
16222934
18.

Getting adequate information across to colorectal cancer screening subjects can be difficult.

van Rijn AF, van Rossum LG, Deutekom M, Laheij RJ, Bossuyt PM, Fockens P, Dekker E, Jansen JB.

J Med Screen. 2008;15(3):149-52. doi: 10.1258/jms.2008.008028.

PMID:
18927098
19.

Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain).

Peris M, Espinàs JA, Muñoz L, Navarro M, Binefa G, Borràs JM; Catalan Colorectal Cancer Screening Pilot Programme Group.

J Med Screen. 2007;14(2):81-6.

PMID:
17626707
20.

Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography: study protocol for a multicenter randomized trial.

Regge D, Iussich G, Senore C, Correale L, Hassan C, Bert A, Montemezzi S, Segnan N.

Trials. 2014 Mar 28;15:97. doi: 10.1186/1745-6215-15-97.

Items per page

Supplemental Content

Write to the Help Desk